Ludwig Trillo Alvarez

Medicine & Life Sciences

1. Treatment-Resistant Depressive Disorder 100%
2. Withholding Treatment 89%
3. aspartic acid receptor 89%
4. Pharmacogenetics 84%
5. Transcranial Magnetic Stimulation 83%
6. Smoking Cessation 74%
7. N-Methyl-D-Aspartate Receptors 74%
8. Traumatic Brain Injury 73%
9. Mood Disorders 72%
10. Alzheimer Disease 57%
11. Systematic Reviews 54%
12. Cytochrome P-450 CYP2B6 53%
13. Depression 48%
14. Genetic Polymorphisms 39%
15. Therapeutics 38%
16. Genetic Testing 38%
17. Drug Interactions 36%
18. Genetic Variation 35%
19. Genes 34%
20. Smokers 31%
21. Decision Making 30%
22. Antidepressive Agents 26%
23. Drug Therapy 21%
24. Biogenic Amines 19%
25. Raphe Nuclei 16%
26. Major Depressive Disorder 15%
27. Gyrus Cinguli 15%
28. Neurons 15%
29. Locus Coeruleus 14%
30. Bipolar Disorder 14%
31. Sample Size 13%
32. Neurotransmitter Agents 12%
33. Genome-Wide Association Study 12%
34. Therapeutic Uses 12%
35. Seizures 11%
36. Chronic Disease 10%
37. Population 10%
38. Magnetic Resonance Imaging 9%
39. Cognition 9%
40. Confidence Intervals 8%
41. Pathology 7%
42. Brain 7%
43. Pharmaceutical Preparations 6%